MANX HEALTHCARE LIMITEDActive

Company number 02904497Private limited companyIncorporated 1994
⚠ Confirmation statement overdue. It was due on 29 Sep 2026.

Key figures

£3,993,696+343.7%
Net assets 2024/25
+36.3%
Average annual growth 2019/20–2024/25
-2 m02 m4 m2019/202020/212021/222023/242024/25

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
010 m20 m2019/202020/212021/222023/242024/25
Filed accounts2019/20–2024/25
2019/202020/212021/222023/242024/25
Turnover———18,629,79912,606,773
Profit for the year———-1,862,0285,632,612
Cash at bank and in hand540,317236,805286,394631,504686,747
Total assets7,286,7398,472,3959,367,00912,557,77117,473,266
Total liabilities—————
Net assets / total equity1,158,5421,103,500448,312-1,638,9163,993,696
Average number of employees2329333331
Average pay (per year)———80,02375,626

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: MANX HEALTHCARE LIMITED

Company

MANX HEALTHCARE LIMITED is a private limited company registered with Companies House under company number 02904497. It was incorporated on 3 Mar 1994. Its status is active. The registered office is in Warwick (CV34). Its nature of business (SIC 2007) is manufacture of basic pharmaceutical products (21100), wholesale of pharmaceutical goods (46460).

Accounts

The latest accounts in the database are for 2024/25 (period ending 29 Sep 2025); the company files medium company accounts. Turnover was £12,606,773. Profit for the year was £5,632,612. Net assets were £3,993,696, up 343.7% on the previous year. Cash at bank and in hand was £686,747. The company had an average of 31 employees. Figures are available for 5 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered. 2 of 9 registered charges are outstanding.

Filing deadlines

The next accounts are due by 29 Jun 2027. The next confirmation statement is due by 29 Sep 2026.